[Ser4(tBu)]-Cetrorelix incorporates a tert-butyl-protected serine at position four, modifying steric bulk and local hydrogen-bonding capacity. The protected residue alters polarity and retention properties during purification. Researchers examine its behavior as a synthetic intermediate and structural analog. Applications include SPPS optimization, analog comparison, and protecting-group evaluation.
CAT No: R2726
[Ser4(tBu)]-Cetrorelix is a synthetic decapeptide analog belonging to the class of gonadotropin-releasing hormone (GnRH) antagonists, distinguished by the incorporation of a tert-butyl protected serine residue at position four. This structural modification enhances its physicochemical properties, offering improved stability and altered receptor interactions compared to unmodified cetrorelix. As a research tool, [Ser4(tBu)]-Cetrorelix is valued for its ability to modulate the hypothalamic-pituitary-gonadal axis by competitively inhibiting endogenous GnRH binding, making it an important molecule for studies focused on reproductive biology, endocrinology, and peptide-receptor dynamics.
Peptide antagonist mechanism studies: As a potent GnRH antagonist, [Ser4(tBu)]-Cetrorelix is widely used to investigate the molecular mechanisms of GnRH receptor blockade. Researchers employ this peptide to dissect the downstream signaling events triggered by receptor inhibition, providing insights into the modulation of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) release. The presence of the tert-butyl-protected serine residue offers a unique opportunity to study how specific side chain modifications influence receptor affinity and antagonist activity, thereby advancing the understanding of structure-activity relationships in peptide-receptor interactions.
Peptide stability and pharmacokinetics research: The tert-butyl modification at the serine position is leveraged in experimental settings to assess the impact of side chain protection on peptide stability, solubility, and resistance to enzymatic degradation. Investigators utilize [Ser4(tBu)]-Cetrorelix as a model system to evaluate how such modifications can extend peptide half-life or alter biodistribution profiles in vitro and in relevant animal models. These studies inform the rational design of next-generation peptide therapeutics and research reagents with optimized pharmacological properties.
Reproductive endocrinology models: By selectively antagonizing GnRH receptors, this peptide enables precise control over gonadotropin secretion in experimental models. It is frequently used in studies aiming to elucidate the regulatory mechanisms underlying the hypothalamic-pituitary-gonadal axis, including the feedback loops governing reproductive hormone synthesis and release. The compound's predictable and reversible action makes it a valuable tool for temporally modulating reproductive hormone levels in both in vitro and in vivo research contexts.
Peptide synthesis and analytical validation: [Ser4(tBu)]-Cetrorelix serves as a reference compound in the development and validation of synthetic peptide production techniques. Its well-characterized sequence and side chain protection profile provide a benchmark for assessing the efficiency of solid-phase peptide synthesis, purification strategies, and analytical methods such as HPLC and mass spectrometry. Researchers benefit from using this analog to optimize protocols and ensure the reproducibility of peptide synthesis workflows, especially when working with sterically hindered or modified amino acid residues.
Receptor binding and competitive displacement assays: The high affinity of this GnRH antagonist for its target receptor makes it an essential reagent for competitive binding studies. It is utilized to quantify receptor-ligand interactions, map binding sites, and evaluate the potency of novel GnRH analogs or antagonists. By serving as a well-defined competitor in displacement assays, [Ser4(tBu)]-Cetrorelix facilitates the characterization of receptor pharmacology and the screening of candidate molecules for research and drug discovery applications.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More